Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — September 2022

Genmab — September 2022

Planlagt Fastgjort Låst Flyttet Genmab
509 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • S Offline
    S Offline
    Stroka
    wrote on sidst redigeret af
    #2

    God morgen 😉

    1 Reply Last reply
    0
    • P Offline
      P Offline
      ProinvestorNEWS
      wrote on sidst redigeret af
      #3

      Godmorgen 🙂

      1 Reply Last reply
      0
      • P Offline
        P Offline
        ProinvestorNEWS
        wrote on sidst redigeret af
        #4

        Torsdagens aviser med Danske Bank, Rockwool og Coloplast https://www.proinvestor.com/investornyt/873591/torsdagens-aviser-med-danske-bank-rockwool-og-coloplast

        1 Reply Last reply
        0
        • P Offline
          P Offline
          ProinvestorNEWS
          wrote on sidst redigeret af
          #5

          Asien: Efteråret starter med udsalg i Asien https://www.proinvestor.com/investornyt/873592/asien-efteraret-starter-med-udsalg-i-asien

          1 Reply Last reply
          0
          • P Offline
            P Offline
            ProinvestorNEWS
            wrote on sidst redigeret af
            #6

            Debatten om Mærsk: "køb billigt" eller "sælg billigt" kører derudaf. Værterne kommer også ind på Bavarian Nordics svingende aktiependul. Derudover diskuteres Jackson Hole, og den enorme effekt det har haft på investorerne. Der sluttes af med danske life-science-selskaber, og hvordan de skubber USD-boomet foran sig. Lyt til afsnit 133 af Investeringspodcasten med Hansen og Larsen her. https://www.proinvestor.com/boards/105797

            1 Reply Last reply
            0
            • SolsenS Offline
              SolsenS Offline
              Solsen
              wrote on sidst redigeret af
              #7

              Godt gået at en analytiker tør gå helt skævt af stort set alle sine kollegaer !

              1 Reply Last reply
              0
              • StockBullS Offline
                StockBullS Offline
                StockBull
                wrote on sidst redigeret af
                #8

                Golden Cross Appears Before Genmab Investors
                If history is any guide, there may be good fortune ahead for shares of
                GENMAB
                (NASDAQ:GMAB). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.
                WHAT TO KNOW:
                Many traders use moving average crossover systems to make their decisions.
                When a shorter-term average price crosses above a longer-term average price, it could mean the stock is trending higher. If the short-term average price crosses

                1 Reply Last reply
                0
                • StockBullS Offline
                  StockBullS Offline
                  StockBull
                  wrote on sidst redigeret af
                  #9

                  below the long-term average price, it means the trend is lower.

                  WHY IT'S IMPORTANT:
                  The 50-day and the 200-day simple moving averages are commonly used.

                  The golden cross occurs when the 50-day crosses above the 200-day. This could mean the long-term trend is changing.

                  That just happened with Genmab, which is trading around $35.63 at publication time.

                  1 Reply Last reply
                  0
                  • D Offline
                    D Offline
                    deleted-user
                    wrote on sidst redigeret af
                    #10

                    @Pensionisten. Tak for deling. Flot opjustering af Société Générale. Niveauet vil der altid være delte meninger om og man kan da undres over, at Société Générale finder +25 % på kursmålet i disse dage med stigende renter. Mon det alene er godkendelsen Tecvayli eller en erkendelse af, at virkeligheden er løbet fra det tidligere kursmål?

                    1 Reply Last reply
                    0
                    • J Offline
                      J Offline
                      JKY_VH
                      wrote on sidst redigeret af
                      #11

                      Når der er forskel på teori og virkelighed, gør man klogt i at forholde sig til virkeligheden;-)

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #12

                        PharmCube
                        @pharmcube
                        ·
                        30 aug.
                        Janssen's Class 1 new drug, teclistamab for injection, is to receive breakthrough therapy designation in #China for patients with r/r maultiple #myeloma who have received at least 3 lines of treatment. https://twitter.com/pharmcube/status/1564547202709536768

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #13

                          Mim8 data sees potential as once monthly treatment for haemophilia A https://pharmaceuticalmanufacturer.media/pharma-manufacturing-news/new-drug-development-approvals-regulatory-news/mim8-data-sees-potential-as-once-monthly-treatment-for-haemo/

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #14

                            Overview of the Mim8 FRONTIER clinical development program http://www.postersessiononline.eu/173580348_eu/congresos/WFH2022/aula/-PO_17_WFH2022.pdf

                            1 Reply Last reply
                            0
                            • P Offline
                              P Offline
                              ProinvestorNEWS
                              wrote on sidst redigeret af
                              #15

                              Aktier/Sydbank: Efteråret kan blive hedt https://www.proinvestor.com/investornyt/873657/aktier-sydbank-efteraret-kan-blive-hedt

                              1 Reply Last reply
                              0
                              • P Offline
                                P Offline
                                ProinvestorNEWS
                                wrote on sidst redigeret af
                                #16

                                ATP-aktiechef: Reduktion i danske aktier en nødvendighed - Mærsk ramt https://www.proinvestor.com/investornyt/873713/atp-aktiechef-reduktion-i-danske-aktier-en-nodvendighed-maersk-ramt

                                1 Reply Last reply
                                0
                                • A Offline
                                  A Offline
                                  AaBforever
                                  wrote on sidst redigeret af
                                  #17

                                  Børsen:
                                  Novo Nordisk har købt det amerikanske biotekselskab Forma Therapeutics for en pris på 1,1 mia. dollar (8,2 mia. kr.), skriver selskabet i en børsmeddelelse.

                                  1 Reply Last reply
                                  0
                                  • P Offline
                                    P Offline
                                    ProinvestorNEWS
                                    wrote on sidst redigeret af
                                    #18

                                    Kort video: .....update på Bavarian Nordic . Slutteligt fortæller Helge Larsen om overeksponering, og hvordan det i 2004 kostede ham dyrt. https://www.proinvestor.com/boards/105815

                                    1 Reply Last reply
                                    0
                                    • G Offline
                                      G Offline
                                      gdn55
                                      wrote on sidst redigeret af
                                      #19

                                      Det er lidt ærgerligt, at de store fonde, banker o.s.v, kan handle som anonyme. De er gode til at give gode råd, især for dem selv. Den ene dårlig dom over aktier efter den anden. Men hvem køber alle disse aktier?

                                      1 Reply Last reply
                                      0
                                      • D Offline
                                        D Offline
                                        deleted-user
                                        wrote on sidst redigeret af
                                        #20

                                        US renten tog lige +4,5 i dag og giver et godt skub til FX'en. Genmab kommer til at opjustere med yderligere ca. 300 mio. kr. på valutafronten når vi rammer 31/12. Det fordrer for gode lønforhøjelser i selskabet, så de ansatte kan sikres mod inflationen.

                                        1 Reply Last reply
                                        0
                                        • Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktør
                                          wrote on sidst redigeret af
                                          #21

                                          Completion of share buy-back program https://www.proinvestor.com/investornyt/873980/completion-of-share-buy-back-program

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper